Cargando…

Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review

SIMPLE SUMMARY: Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary central nervous system lymphoma (PCNSL). ALCL is divided into anaplastic lymphoma kinase (ALK)-positive ALCL and ALK-negative ALCL, according to ALK expression. ALK-positive canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirano, Yudai, Miyawaki, Satoru, Tanaka, Shota, Taoka, Kazuki, Hongo, Hiroki, Teranishi, Yu, Takami, Hirokazu, Takayanagi, Shunsaku, Kurokawa, Mineo, Saito, Nobuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431692/
https://www.ncbi.nlm.nih.gov/pubmed/34503168
http://dx.doi.org/10.3390/cancers13174358
_version_ 1783750997270593536
author Hirano, Yudai
Miyawaki, Satoru
Tanaka, Shota
Taoka, Kazuki
Hongo, Hiroki
Teranishi, Yu
Takami, Hirokazu
Takayanagi, Shunsaku
Kurokawa, Mineo
Saito, Nobuhito
author_facet Hirano, Yudai
Miyawaki, Satoru
Tanaka, Shota
Taoka, Kazuki
Hongo, Hiroki
Teranishi, Yu
Takami, Hirokazu
Takayanagi, Shunsaku
Kurokawa, Mineo
Saito, Nobuhito
author_sort Hirano, Yudai
collection PubMed
description SIMPLE SUMMARY: Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary central nervous system lymphoma (PCNSL). ALCL is divided into anaplastic lymphoma kinase (ALK)-positive ALCL and ALK-negative ALCL, according to ALK expression. ALK-positive cancers tend to develop at a younger age and tend to have a better prognosis. Almost all past articles on primary ALCL of the CNS have been case reports and there have been no randomized trials or cohort studies on this subject. We thus performed a systematic review of primary ALCL of the CNS. According to the author’s survey, 36 case reports have been published in English-language journals. In this paper, we have summarized the clinical features and prognostic factors for primary ALCL of the CNS based on previous studies. ABSTRACT: Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary CNS lymphoma (PCNSL). There are very few comprehensive reports on this extremely rare tumor. Therefore, it is necessary to investigate the clinical features and prognostic factors for primary ALCL of the CNS. We performed a systematic review of the published literature. Past cases were comprehensively searched using PubMed, Cochrane Library, and Web of Science. Clinical information, such as age, sex, anaplastic lymphoma kinase (ALK) status, lesion sites, treatment methods, and survivorship were extracted. Thirty-nine cases with information on ALK status and treatment course were identified. The average observation period was 13 months, and the overall 2-year survival rate was 58%. Univariate analyses showed a statistically significantly better prognosis among patients < 40 years of age (p = 0.039, HR 0.32 (0.11–0.95)) and in relation to ALK positivity (p = 0.010, HR 0.24 (0.08–0.71) and methotrexate treatment (p = 0.003, HR 0.17 (0.05–0.56)). Because of the sparsity of cases, it is necessary to accumulate cases in order to perform more detailed analyses.
format Online
Article
Text
id pubmed-8431692
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84316922021-09-11 Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review Hirano, Yudai Miyawaki, Satoru Tanaka, Shota Taoka, Kazuki Hongo, Hiroki Teranishi, Yu Takami, Hirokazu Takayanagi, Shunsaku Kurokawa, Mineo Saito, Nobuhito Cancers (Basel) Systematic Review SIMPLE SUMMARY: Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary central nervous system lymphoma (PCNSL). ALCL is divided into anaplastic lymphoma kinase (ALK)-positive ALCL and ALK-negative ALCL, according to ALK expression. ALK-positive cancers tend to develop at a younger age and tend to have a better prognosis. Almost all past articles on primary ALCL of the CNS have been case reports and there have been no randomized trials or cohort studies on this subject. We thus performed a systematic review of primary ALCL of the CNS. According to the author’s survey, 36 case reports have been published in English-language journals. In this paper, we have summarized the clinical features and prognostic factors for primary ALCL of the CNS based on previous studies. ABSTRACT: Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary CNS lymphoma (PCNSL). There are very few comprehensive reports on this extremely rare tumor. Therefore, it is necessary to investigate the clinical features and prognostic factors for primary ALCL of the CNS. We performed a systematic review of the published literature. Past cases were comprehensively searched using PubMed, Cochrane Library, and Web of Science. Clinical information, such as age, sex, anaplastic lymphoma kinase (ALK) status, lesion sites, treatment methods, and survivorship were extracted. Thirty-nine cases with information on ALK status and treatment course were identified. The average observation period was 13 months, and the overall 2-year survival rate was 58%. Univariate analyses showed a statistically significantly better prognosis among patients < 40 years of age (p = 0.039, HR 0.32 (0.11–0.95)) and in relation to ALK positivity (p = 0.010, HR 0.24 (0.08–0.71) and methotrexate treatment (p = 0.003, HR 0.17 (0.05–0.56)). Because of the sparsity of cases, it is necessary to accumulate cases in order to perform more detailed analyses. MDPI 2021-08-28 /pmc/articles/PMC8431692/ /pubmed/34503168 http://dx.doi.org/10.3390/cancers13174358 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Hirano, Yudai
Miyawaki, Satoru
Tanaka, Shota
Taoka, Kazuki
Hongo, Hiroki
Teranishi, Yu
Takami, Hirokazu
Takayanagi, Shunsaku
Kurokawa, Mineo
Saito, Nobuhito
Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review
title Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review
title_full Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review
title_fullStr Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review
title_full_unstemmed Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review
title_short Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review
title_sort clinical features and prognostic factors for primary anaplastic large cell lymphoma of the central nervous system: a systematic review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431692/
https://www.ncbi.nlm.nih.gov/pubmed/34503168
http://dx.doi.org/10.3390/cancers13174358
work_keys_str_mv AT hiranoyudai clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview
AT miyawakisatoru clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview
AT tanakashota clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview
AT taokakazuki clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview
AT hongohiroki clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview
AT teranishiyu clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview
AT takamihirokazu clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview
AT takayanagishunsaku clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview
AT kurokawamineo clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview
AT saitonobuhito clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview